Jupiter Wellness, Inc. (JUPW)

0.6400 +0.0052 (+0.82%) At close: 04:00PM EST

Jupiter Wellness, Inc.

1061 East Indiantown Road
Suite 110
Jupiter, FL 33477
United States
561 244 7100
https://www.jupiterwellness.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 12

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Glynn Wilson Ph.D.	Chief Science Officer & Chairman	121.88k	N/A	1947
Mr. Brian Scott John	Chief Investment Officer, CEO & Exec. Director	263.12k	N/A	1969
Mr. Richard A. Miller	Sec.	194.16k	N/A	1968
Mr. Douglas O. McKinnon	Chief Financial Officer	N/A	N/A	1951
Dr. Andy Goren M.D.	Chief Medical Officer & Member of Scientific Advisory Board	N/A	N/A	1972

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Corporate Governance

Jupiter Wellness, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.